Dr. Chonat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1405 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-785-1112Fax+1 404-785-6288
Education & Training
- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2012 - 2015
- Sparrow HospitalResidency, Pediatrics, 2009 - 2012
- Cambridge University Hospitals and London School of PaediatricsSpeciality Training Registrar, General Pediatrics, Neonatology and Hematology/Oncology, 2003 - 2009
- M.S. Ramaiah Medical CollegeClass of 2003
Certifications & Licensure
- GA State Medical License 2015 - 2025
- OH State Medical License 2012 - 2017
- MI State Medical License 2009 - 2012
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Pyruvate Kinase Deficiency Natural History Study Start of enrollment: 2013 Dec 01
- A Study of Ravulizumab (ALXN1210) in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria Start of enrollment: 2018 Feb 22
- Pyruvate Kinase Deficiency Global Longitudinal Registry Start of enrollment: 2018 Apr 23
- Join now to see all
Publications & Presentations
PubMed
- Fatal thrombotic microangiopathy during induction for acute myeloid leukemia: A case report and review of vascular complications in germline GATA2 haploinsufficiency.Erin L Frost, Satheesh Chonat, Kirsten M Williams, Waitman Aumann, Jason Stevenson
British Journal of Haematology. 2024-12-08 - Harnessing the potential of red blood cells in immunotherapy.Ryan P Jajosky, Patricia E Zerra, Satheesh Chonat, Sean R Stowell, Connie M Arthur
Human Immunology. 2024-11-01 - Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria.Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, Saskia Langemeijer, Satheesh Chonat
American Journal of Hematology. 2024-11-01
Abstracts/Posters
- Congenital Dyserythropoietic Anemia Type I Due to Biallelic CDAN1 mutations: Report from the Congenital Dyserythropoietic Anemia Registry (CDAR)Satheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Comorbidities and Complications in Adults with Pyruvate Kinase DeficiencySatheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Characterization of the Severe Phenotype of Pyruvate Kinase DeficiencySatheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
- Rezurock Approved for Chronic Graft-vs-Host DiseaseAugust 4th, 2021
- Ultomiris Approved for Pediatric Patients with Paroxysmal Nocturnal HemoglobinuriaJune 8th, 2021
- Alexion Announces FDA Approval of ULTOMIRIS® (Ravulizumab-Cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)June 7th, 2021
External Links
- Chonat Labhttps://www.pedsresearch.org/research-group/chonat-laboratory
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: